ACT for ALS Reauthorization Act Introduced in the Senate
ALS Network applauds the bipartisan legislation to sustain momentum in ALS research and access to investigational therapies
The bill was introduced just in time for ALS Awareness Month. Members of the ALS Network and ALS United will be in
ACT for ALS established a patient-centered approach to accelerate progress on two critical fronts: advancing research and expanding access to investigational therapies for people who are unable to participate in traditional clinical trials. These efforts are critical for a disease where time is limited and effective treatment options remain few.
Without reauthorization, programs expanding access to investigational therapies and the research infrastructure driving ALS treatment and research discoveries will begin to wind down, disrupting progress for patients, families, and researchers. The ALS Network calls on Congress to act swiftly to reauthorize this vital legislation (S.4472/H.R.8205) and sustain momentum across the ALS research ecosystem.
About the ALS Network
The ALS Network partners with the ALS community to drive the discovery of prevention strategies, treatments, and cures for ALS; provide access to quality care and connection; and promote initiatives to improve health outcomes. The ALS Network, formerly ALS
Media Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/act-for-als-reauthorization-act-introduced-in-the-senate-302760514.html
SOURCE ALS Network
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Democratic Republic of Congo Launches Landmark "Invest in the DRC" Advertising Campaign in United States
- Ethereum News: Why Pepeto’s $10.3 Million Presale Grows While ETH Restructures
- SENIX Announces Prime Day Deal on 21-Inch Self-Propelled Gas Lawn Mower as Homeowners Tackle Peak Summer Yard Care
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share